1. Home
  2. LXRX vs EQV Comparison

LXRX vs EQV Comparison

Compare LXRX & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • EQV
  • Stock Information
  • Founded
  • LXRX 1995
  • EQV 2024
  • Country
  • LXRX United States
  • EQV United States
  • Employees
  • LXRX N/A
  • EQV N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • EQV
  • Sector
  • LXRX Health Care
  • EQV
  • Exchange
  • LXRX Nasdaq
  • EQV Nasdaq
  • Market Cap
  • LXRX 552.4M
  • EQV 463.6M
  • IPO Year
  • LXRX 2000
  • EQV 2024
  • Fundamental
  • Price
  • LXRX $1.37
  • EQV $10.43
  • Analyst Decision
  • LXRX Buy
  • EQV
  • Analyst Count
  • LXRX 5
  • EQV 0
  • Target Price
  • LXRX $3.23
  • EQV N/A
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • EQV 43.5K
  • Earning Date
  • LXRX 11-04-2025
  • EQV 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • EQV N/A
  • EPS Growth
  • LXRX N/A
  • EQV N/A
  • EPS
  • LXRX N/A
  • EQV N/A
  • Revenue
  • LXRX $58,432,000.00
  • EQV N/A
  • Revenue This Year
  • LXRX $66.55
  • EQV N/A
  • Revenue Next Year
  • LXRX N/A
  • EQV N/A
  • P/E Ratio
  • LXRX N/A
  • EQV $50.95
  • Revenue Growth
  • LXRX 1504.83
  • EQV N/A
  • 52 Week Low
  • LXRX $0.28
  • EQV $9.91
  • 52 Week High
  • LXRX $2.08
  • EQV $10.74
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 48.43
  • EQV 65.45
  • Support Level
  • LXRX $1.36
  • EQV $10.40
  • Resistance Level
  • LXRX $1.48
  • EQV $10.43
  • Average True Range (ATR)
  • LXRX 0.10
  • EQV 0.03
  • MACD
  • LXRX -0.02
  • EQV 0.00
  • Stochastic Oscillator
  • LXRX 3.33
  • EQV 83.33

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About EQV EQV Ventures Acquisition Corp.

EQV Ventures Acquisition Corp is a blank check company.

Share on Social Networks: